Unaudited Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net loss	$ (45,816)	$ (79,093)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	8,761	9,371
Stock-based compensation expense	2,275	3,211
Inventory impairments and option contract abandonments	2,246	11,071
Deferred and other income tax benefit	(485)	(36,378)
Provision for doubtful accounts	(190)	(1,678)
Equity in loss of unconsolidated entities	207	62
Cash distributions of income from unconsolidated entities	336	0
Loss on extinguishment of debt	1,517	2,747
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable	(1,277)	9,381
Decrease in income tax receivable	3,292	2,425
(Increase) decrease in inventory	(159,753)	4,091
Decrease in other assets	559	5,442
Increase in trade accounts payable	10,357	778
Decrease in other liabilities	(20,274)	(37,813)
Other changes	51	(29)
Net cash used in operating activities	(198,194)	(106,412)
Cash flows from investing activities:
Capital expenditures	(6,572)	(15,117)
Investments in unconsolidated entities	(1,374)	(2,075)
Return of capital from unconsolidated entities	432	440
Increases in restricted cash	(1,788)	(1,679)
Decreases in restricted cash	9,035	6,955
Net cash used in investing activities	(267)	(11,476)
Cash flows from financing activities:
Repayment of debt	(185,431)	(3,369)
Proceeds from issuance of new debt	200,000	0
Debt issuance costs	(4,935)	(274)
Equity issuance costs	0	(1,296)
Settlement of unconsolidated entity debt obligation	(500)	(15,862)
Payments for other financing activities	(122)	(98)
Net cash provided by (used in) financing activities	9,012	(20,899)
Decrease in cash and cash equivalents	(189,449)	(138,787)
Cash and cash equivalents at beginning of period	487,795	370,403
Cash and cash equivalents at end of period	$ 298,346	$ 231,616